These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study of treatment nonalcoholic fatty liver with qianggan capsule].
    Author: Chen ZX, Zhang SJ, Yun LR.
    Journal: Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(20):1739-41. PubMed ID: 17225548.
    Abstract:
    OBJECTIVE: To investigate the therapeutic effect of Qianggan capsule on the treatment of nonalcoholic fatty liver. METHODS: One hundred and twenty-two patients of nonalcoholic fatty liver were randomly divided into two groups, 64 patients in the treated group were treated by Qianggan capsule, 5 granule every time, twice per day and the 58 patients in control group were treated by tiopronin, 0. 2 gram every time, third per day with a therapeutic course of 3 months. RESULT: Serum levels of ALT and gamma-GT were decreased significantly after the treatment of Qianggan capsule (P <0.05). However, TG levels seemed decreased but have not significant difference after the treatment of Qianggan capsule. The serum level of ALT in control group decreased markedly after treatment (P < 0.05), but no obvious change was seen in gamma-GT and TG in control group after treatment. The total effective rate in the treated group was higher than those in the control group (79.69% vs 62.07%, P < 0.05). CONCLUSION: Qianggan capsule is an effective recipe in treating nonalcoholic fatty liver.
    [Abstract] [Full Text] [Related] [New Search]